One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Journals package 3months
-
http://medilib.ir
- Duration of Time : 93 Day
Price : 100$- Special Price : 50$
New treatments and biomarkers in heart failure, hypertrophic cardiomyopathy, and familial hypercholesterolaemia
From data to perception: visualizing bias in artificial intelligence-generated images
TAVI or TAVR: it is time to use a single standardized acronym for percutaneous aortic valve implantation
An update on the ESC Council on Cardiovascular Genomics: out from the niche into the open
High intensity exercise programme in patients with hypertrophic cardiomyopathy: a randomized trial
Exercise prescription in hypertrophic cardiomyopathy: Dr Lown’s lesson to break taboos
Fibroblast growth factor 5: a novel biomarker for familial hypercholesterolaemia
Expanding the triglyceride range in clinical trials: therapeutic opportunities
Reaching for the stars: a wider perspective for designing future cardiovascular outcome trials of triglyceride-lowering therapies
High temperature and cardiovascular disease in Australia under different climatic, demographic, and adaptive scenarios
Autophagy is required for the therapeutic effects of the NAD� precursor nicotinamide in obesity-related heart failure with preserved ejection fraction
Cardiovascular safety of assisted reproductive technologies: what have we learned and what remains unknown?
Cardiovascular safety of assisted reproductive technologies: what is next?
Weekly Journal Scan: Myocarditis related to COVID-19 mRNA vaccination has less severe course than those associated to SARS-CoV-2 infection or conventional aetiology
